Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Ezra Cohen

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Cohen, Ezra

Item TypeName
Concept American Cancer Society
Concept Breast Neoplasms
Concept Urinary Bladder Neoplasms
Concept Colonic Neoplasms
Concept Kidney Neoplasms
Concept Laryngeal Neoplasms
Concept Oropharyngeal Neoplasms
Concept Lung Neoplasms
Concept Head and Neck Neoplasms
Concept Salivary Gland Neoplasms
Concept Tongue Neoplasms
Concept Neoplasms, Second Primary
Concept Mouth Neoplasms
Concept Skin Neoplasms
Concept Colorectal Neoplasms
Concept Thyroid Neoplasms
Concept Early Detection of Cancer
Concept Muscle Neoplasms
Concept Esophageal Neoplasms
Concept Hypopharyngeal Neoplasms
Concept Nasopharyngeal Neoplasms
Concept Neoplasms
Academic Article Treatment of metastatic urothelial cancer in the post-MVAC era.
Academic Article Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.
Academic Article Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
Academic Article Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Academic Article Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Academic Article Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.
Academic Article A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.
Academic Article A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.
Academic Article Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
Academic Article The expanding role of systemic therapy in head and neck cancer.
Academic Article The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Academic Article A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.
Academic Article Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Academic Article Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Academic Article Chemoradiation for patients with advanced oral cavity cancer.
Academic Article Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.
Academic Article High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
Academic Article Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
Academic Article Personalizing cancer care: updates on head and neck cancer.
Academic Article Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas.
Academic Article Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
Academic Article [18F]Fluorodeoxyglucose positron emission tomography in the initial staging of squamous cell carcinoma of the head and neck: promise, evidence, and reality.
Academic Article Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.
Academic Article A phase I study of sirolimus and bevacizumab in patients with advanced malignancies.
Academic Article Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Academic Article The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients.
Academic Article A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Academic Article Airway management before chemoradiation for advanced head and neck cancer.
Academic Article Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Academic Article Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
Academic Article Free-flap reconstruction in the doubly irradiated patient population.
Academic Article Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
Academic Article Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
Academic Article Predictors of competing mortality in advanced head and neck cancer.
Academic Article Planned post-chemoradiation neck dissection: significance of radiation dose.
Academic Article Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.
Academic Article Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas.
Academic Article A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.
Academic Article Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Academic Article Thyroid cancer: burden of illness and management of disease.
Academic Article Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
Academic Article Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.
Academic Article Single sample expression-anchored mechanisms predict survival in head and neck cancer.
Academic Article Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model.
Academic Article Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.
Academic Article A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Academic Article The next phase of chemoprevention research.
Academic Article Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck.
Academic Article Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Academic Article A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.
Academic Article Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
Academic Article Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
Academic Article Role of molecular markers in the management of head and neck cancers.
Academic Article Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin.
Academic Article Two drug interaction studies of sirolimus in combination with sorafenib or sunitinib in patients with advanced malignancies.
Academic Article Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers.
Academic Article Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients.
Academic Article Searching for a standard.
Academic Article Locally advanced non-small cell lung cancer.
Academic Article Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
Academic Article Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line.
Academic Article Esophageal cancer therapy: a decade of inertia.
Academic Article ONYX-015. Onyx Pharmaceuticals.
Academic Article Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy.
Academic Article Introduction: head and neck cancer.
Academic Article Surrogate endpoints in head and neck cancer.
Academic Article A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
Academic Article Cabozantinib for the treatment of advanced medullary thyroid cancer.
Academic Article mTOR: the mammalian target of replication.
Academic Article Design of Phase II cancer trials for evaluation of cytostatic/cytotoxic agents.
Academic Article Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.
Academic Article Current treatment options for metastatic head and neck cancer.
Academic Article Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patients.
Academic Article Novel therapeutic targets in squamous cell carcinoma of the head and neck.
Academic Article State-of-the-art management of locally advanced head and neck cancer.
Academic Article Mechanisms of resistance to EGFR inhibitors in head and neck cancer.
Academic Article Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Academic Article A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFeradeā„¢ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
Academic Article New approaches to thyroid cancer.
Academic Article Novel molecular targeted therapies for refractory thyroid cancer.
Academic Article Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA.
Academic Article Pharmacoeconomic issues in head and neck oncology.
Academic Article Forthcoming receptor tyrosine kinase inhibitors.
Academic Article Nonlinear population pharmacokinetics of sirolimus in patients with advanced cancer.
Academic Article Treatment of squamous cell carcinoma of the head and neck in the metastatic and refractory settings: advances in chemotherapy and the emergence of small molecule epidermal growth factor receptor kinase inhibitors.
Academic Article Targeting angiogenesis in head and neck cancer.
Academic Article Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.
Academic Article New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors.
Academic Article Diastolic blood pressure as a biomarker of axitinib efficacy in solid tumors.
Academic Article Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition.
Academic Article Novel targeted therapies in head and neck cancer.
Academic Article The role of chemotherapy in locally advanced head and neck squamous cell carcinoma.
Academic Article The future of induction chemotherapy for head and neck squamous cell carcinoma.
Academic Article Multidisciplinary care of the patient with head and neck cancer.
Academic Article An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.
Academic Article Epidermal growth factor receptor directed therapy in head and neck cancer.
Academic Article Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Academic Article Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
Academic Article Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].
Academic Article Modifiable risk behaviors in patients with head and neck cancer.
Academic Article Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.
Academic Article Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis.
Academic Article Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Academic Article Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.
Academic Article Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.
Academic Article Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.
Academic Article DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
Academic Article Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
Academic Article Race and competing mortality in advanced head and neck cancer.
Academic Article Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.
Academic Article Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
Academic Article Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.
Academic Article A qualitative evaluation of the validity of published health utilities and generic health utility measures for capturing health-related quality of life (HRQL) impact of differentiated thyroid cancer (DTC) at different treatment phases.
Academic Article Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss.
Academic Article Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements.
Academic Article Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.
Academic Article A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses.
Academic Article Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy.
Academic Article Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.
Academic Article Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
Academic Article Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapy.
Academic Article Cabozantinib in progressive medullary thyroid cancer.
Academic Article Open Access in biomedical sciences: what the current turning point means more specifically to Oral Oncology contributors and readers.
Academic Article Reply to s. Chakraborty et al.
Academic Article Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN).
Academic Article Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab.
Academic Article Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Academic Article An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck.
Academic Article A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours.
Academic Article p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.
Academic Article A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck.
Academic Article Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments.
Academic Article Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab.
Academic Article Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy.
Academic Article Towards a personalized treatment of head and neck cancer.
Academic Article Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.
Academic Article Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Academic Article Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide.
Academic Article Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo.
Academic Article Lenvatinib in Advanced, Radioactive Iodine-Refractory, Differentiated Thyroid Carcinoma.
Academic Article Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Academic Article Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.
Academic Article Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.
Academic Article A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis.
Academic Article Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer.
Academic Article American Cancer Society Head and Neck Cancer Survivorship Care Guideline.
Academic Article Considering the survivorship care needs of head and neck cancer survivors.
Academic Article Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial.
Academic Article Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
Academic Article Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.
Academic Article Interdisciplinary Oncology Education: a National Survey of Trainees and Program Directors in the United States.
Academic Article Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.
Academic Article PI3K? is a molecular switch that controls immune suppression.
Academic Article A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer (HNC).
Academic Article Use of systematic analysis of DNA repair pathways in head and neck cancer (HNC) to identify XPF as a novel predictor of induction response, and pMK2 relationship to chemoradiotherapy.
Academic Article Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC) - a Phase II Trial.
Academic Article Phase 2 study of sunitinib in refractory thyroid cancer.
Academic Article Phase II trial of sequential bevacizumab (B), erlotinib (E) and chemotherapy for first line treatment of clinical stage IIIB or IV non-small cell lung cancer (NSCLC).
Academic Article Phase II trial pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated head and neck cancer patients.
Academic Article Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
Academic Article Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012.
Academic Article Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline.
Academic Article Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Academic Article Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions.
Academic Article Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.
Academic Article Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer.
Academic Article Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience.
Academic Article A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers.
Academic Article Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.
Academic Article A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.
Academic Article Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer.
Academic Article Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer.
Academic Article Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics.
Academic Article A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy.
Academic Article The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Academic Article Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial.
Academic Article Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial.
Academic Article Selection of Head and Neck Cancer Patients for Intensive Therapy.
Academic Article A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors.
Academic Article HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.
Academic Article B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade.
Academic Article Quality of Life With Pembrolizumab for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
Academic Article Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study.
Academic Article The Changing Landscape of Therapeutic Cancer Vaccines - Novel Platforms and Neoantigen Identification.
Academic Article Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer.

Search Criteria
  • Cancer